A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The primary objective of the study is to evaluate and compare the effect of iron isomaltoside 1000 to placebo in its ability to increase haemoglobin (Hb) in subjects with IDA when oral iron preparations are ineffective or cannot be used.
Epistemonikos ID: 7127491db1bb6272bc0094d5e8b61fad2cb5714c
First added on: May 11, 2024